Atlas Trials

A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

Clinical trial NCT00039754 · TERMINATED

Trial details

NCT number
NCT00039754
Sponsor
Poniard Pharmaceuticals
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2002-03-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.